Combined therapy of chronic viral hepatitis c in children with phosphogliv

   
Mukhamedov N.B.1 , Inoyatova F.I.1 , Aripov O.A.1 , Aripov A.N.1

1. Research Institute of pediatrics
Section: Experimental/Clinical Study
PubMed Id: 14569880
Year: 2003  Volume: 49  Issue: 1  Pages: 105-109
Two schemes of the treatment of chronic hepatitis C were compared. Each scheme included 40 medical treatment for 2 months. 22 patients received basic therapy including phosphogliv, 3-5 procedures of ultraviolet irradiation of blood (UVIB) and roferon (the course was begun after the 2-nd procedure of UVIB). 18 patients received basic therapy with phosphogliv, UVIB and T-activin (the course also was begun after the second procedure of UVIB). The patients were observed for 9 months. An advantage of the combination of phosphogliv, UVIB and roferon, providing a stable remission in 36,3% of the patients for 9 months was demonstrated.
Download PDF:  
Citation:

Mukhamedov, N. B., Inoyatova, F. I., Aripov, O. A., Aripov, A. N. (2003). Combined therapy of chronic viral hepatitis c in children with phosphogliv. Biomeditsinskaya Khimiya, 49(1), 105-109.
References  
 2026 (vol 72)
 2025 (vol 71)
 2024 (vol 70)